PTCSC3 Is Involved in Papillary Thyroid Carcinoma Development by ModulatingS100A4Gene Expression
Author(s) -
Jarosław Jendrzejewski,
Andrew Thomas,
Sandya Liyanarachchi,
Andrew Eiterman,
Jerneja Tomšič,
Huiling He,
Hanna S. Radomska,
Wei Li,
Rebecca Nagy,
Krzysztof Sworczak,
Albert de la Chapelle
Publication year - 2015
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2015-2247
Subject(s) - thyroid carcinoma , biology , carcinogenesis , gene expression , thyroid , cancer research , microbiology and biotechnology , thyroid cancer , western blot , cell culture , real time polymerase chain reaction , gene , pathology , endocrinology , medicine , genetics
We previously showed that a long noncoding RNA gene, PTCSC3, located close to the variant rs944289 that predisposes to papillary thyroid carcinoma (PTC) might target the S100A4 gene.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom